Lymphotoxin β receptor-lg fusion protein treatment blocks actively induced, but not adoptively transferred, uveitis in Lewis rats

European Journal of Immunology

Volumn 33, Issue 6, 2003, Pages 1736-1743

  Shao, Hui ^a   Fu, Yangxin ^b   Song, Lei ^a   Sun, Sheler ^a   Kaplan, Herry J ^a   Sun, Deming ^a  

^a University of Louisville School of Medicine   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

Autoimmunity; Costimulation; Interphotoreceptor retinoid binding protein; Lymphotoxin receptor lg fusion protein; Uveitis

Indexed keywords

HYBRID PROTEIN; IMMUNOGLOBULIN RECEPTOR; INTERPHOTORECEPTOR RETINOID BINDING PROTEIN; LYMPHOTOXIN; RECEPTOR SUBTYPE; RECOMBINANT PROTEIN; VIRUS ANTIBODY;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNE DISEASE; CELL SPECIFICITY; CELLULAR IMMUNITY; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; FEMALE; HERPES VIRUS; IMMUNOPATHOGENESIS; IMMUNOPROPHYLAXIS; NONHUMAN; PASSIVE IMMUNIZATION; PRIORITY JOURNAL; RAT; RAT STRAIN; T LYMPHOCYTE; UVEITIS;

ADOPTIVE TRANSFER; ANIMALS; AUTOANTIGENS; AUTOIMMUNE DISEASES; FEMALE; IMMUNOCONJUGATES; LYMPHOTOXIN BETA RECEPTOR; LYMPHOTOXIN-ALPHA; MEMBRANE PROTEINS; PEPTIDE FRAGMENTS; RATS; RATS, INBRED LEW; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, MEMBER 14; RECEPTORS, VIRUS; RECOMBINANT FUSION PROTEINS; RETINOL-BINDING PROTEINS; SPECIFIC PATHOGEN-FREE ORGANISMS; T-LYMPHOCYTE SUBSETS; TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 14; TUMOR NECROSIS FACTOR-ALPHA; UVEITIS; VACCINATION;

EID: 0038420931     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200323745     Document Type: Article

References (37)

1. Salomon, B. and Bluestone, J. A., Complexities of cd28/b7: CTLA-4 costimulatory pathways in autoimmunity and transplantation. Annu. Rev. Immunol. 2001. 19: 225-252.
2. Vanderlugt, C. L., Karandikar, N. J., Lenschow, D. J., Dalcanto, M. C. and Bluestone, J. A., Treatment with intact anti-B7-1 mAb during disease remission enhances epitope spreading and exacerbates relapses in R-EAE. J. Neuroimmunol. 1997. 79: 113-118.
3. Lenschow, D. J., Ho, S. C., Sattar, H., Rhee, L., Gray, G., Nabavi, N., Herold, K. C. and Bluestone, J. A., Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse. J. Exp. Med. 1995. 181: 1145-1155.
4. Wu, Q., Salomon, B., Chen, M., Wang, Y., Hoffman, L. M., Bluestone, J. A. and Fu, Y. X., Reversal of spontaneous autoimmune insulitis in nonobese diabetic mice by soluble lymphotoxin receptor. J. Exp. Med. 2001. 193: 1327-1332.
5. Mackay, F., Browning, J. L., Lawton, P., Shah, S. A., Comiskey, M., Bhan, A. K., Mizoguchi, E., Terhorst, C. and Simpson, S. J., Both the lymphotoxin and tumor necrosis factor pathways are involved in experimental murine models of colitis. Gastroenterology 1998. 115: 1464-1475.
6. Locksley, R. M., Killeen, N. and Lenardo, M. J., The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 2001. 104: 487-501.
7. Matsumoto, M., Role of TNF ligand and receptor family in the lymphoid organogenesis defined by gene targeting. J. Med. Invest. 1999. 46: 141-150.
8. Ruddle, N. H., Lymphoid neo-organogenesis: lymphotoxin's role in inflammation and development. Immunol. Res. 1999. 19: 119-125.
9. Futterer, A., Mink, K., Luz, A., Koscovilbois, M. H. and Pfeffer, K., The lymphotoxin β receptor controls organogenesis and affinity maturation in peripheral lymphoid tissues. Immunity 1998. 9: 59-70.
10. Koni, P. A. and Flavell, R. A., A role for tumor necrosis factor receptor type 1 in gut-associated lymphoid tissue development - genetic evidence of synergism with lymphotoxin β. J. Exp. Med. 1998. 187: 1977-1983.
11. Murphy, M., Walter, B. N., Pikenobile, L., Fanger, N. A., Guyre, P. M., Browning, J. L. and Epstein, L. B., Expression of lymphotoxin β receptor on follicular stromal cells in human lymphoid tissues. Cell Death Differ. 1998. 5: 497-505.
12. Koni, P. A., Sacca, R., Lawton, P., Browning, J. L. and Ruddle, N. H., Distinct roles in lymphoid organogenesis for lymphotoxins α and β revealed in lymphotoxin β-deficient mice. Immunity 1997. 6: 491-500.
13. Korner, H., Cook, M., Riminton, D. S., Lemckert, F. A., Hoek, R. M., Ledermann, B., Fazekas de St. Groth, B. and Sedgwick, J. D., Distinct roles for lymphotoxin-alpha and tumor necrosis factor in organogenesis and spatial organization of lymphoid tissue. Eur. J. Immunol. 1997. 27: 2600-2609.
14. Cuff, C. A., Schwartz, J., Bergman, C. M., Russell, K. S., Bender, J. R. and Ruddle, N. H., Lymphotoxin α3 induces chemokines and adhesion molecules: Insight into the role of LT a in inflammation and lymphoid organ development. J. Immunol. 1998. 161: 6853-6860.
15. Mauri, D. N., Ebner, R., Montgomery, R. I., Kochel, K. D., Cheung, T. C., Yu, G. L., Ruben, S., Murphy, M., Eisenberg, R. J., Cohen, G. H., Spear, R G. and Ware, C. F., LIGHT, a new member of the TNF superfamily, and lymphotoxin alpha are ligands for herpesvirus entry mediator. Immunity 1998. 8: 21-30.
16. Browning, J. L., Miatkowski, K., Sizing, I., Griffiths, D., Zafari, M., Benjamin, C. D., Meier, W. and Mackay, F., Signaling through the lymphotoxin beta receptor induces the death of some adenocarcinoma tumor lines. J. Exp. Med. 1996. 183: 867-878.
17. Montgomery, R. I., Warner, M. S., Lum, B. J. and Spear, P. G., Herpes simplex virus-1 entry into cells mediated by a novel member of the TNF/NGF receptor family. Cell 1996. 87: 427-436.
18. Wang, J., Lo, J. C., Foster, A., Yu, P., Chen, H. M., Wang, Y., Tamada, K., Chen, L. and Fu, Y. X., The regulation of T cell homeostasis and autoimmunity by T cell-derived LIGHT. J. Clin. Invest. 2001. 108: 1771-1780.
19. Shaikh, R. B., Santee, S., Granger, S. W., Butrovich, K., Cheung, T., Kronenberg, M., Cheroutre, H. and Ware, C. F., Constitutive expression of LIGHT on T cells leads to lymphocyte activation, inflammation, and tissue destruction. J. Immunol. 2001. 167: 6330-6337.
20. Tamada, K., Tamura, H., Flies, D., Fu, Y. X., Celis, E., Pease, L. R., Blazar, B. R. and Chen, L., Blockade of LIGHT/LTbeta and CD40 signaling induces allospecific T cell anergy, preventing graft-versus-host disease. J. Clin. Invest 2002. 109: 549-557.
21. + T cells are encephalitogenic and produce severe disease in C57BL/6 mice. J. Immunol. 2001. 166: 7579-7587.
22. Sun, D., Coleclough, C. and Hu, X., Heterogeneity of rat encephalitogenic T cells elicited by variants of the MBP(68-88) peptide. Eur. J. Immunol. 1995. 25: 1687-1692.
23. Sun, D., Hu, X., Le, J. and Swanborg, R. H., Characterization of brain-isolated rat encephalitogenic T cell lines. Eur. J. Immunol. 1994. 24: 1359-1364.
24. Riminton, D. S., Korner, H., Strickland, D. H., Lemckert, F. A., Pollard, J. D. and Sedgwick, J. D., Challenging cytokine redundancy - inflammatory cell movement and clinical course of experimental autoimmune encephalomyelitis are normal in lymphotoxin-deficient but not tumor necrosis factor-deficient mice. J. Exp. Med. 1998. 187: 1517-1528.
25. Fu, Y. X., Molina, H., Matsumoto, M., Huang, G., Min, J. and Chaplin, D. D., Lymphotoxin-alpha (LTα) supports development of splenic follicular structure that is required for IgG responses. J. Exp. Med. 1997. 185: 2111-2120.
26. Fu, Y. X. and Chaplin, D. D., Development and maturation of secondary lymphoid tissues. Annu. Rev. Immunol. 1999. 17: 399-433.
27. Iizuka, K., Chaplin, D. D., Wang, Y., Wu, Q., Pegg, L. E., Yokoyama, W. M. and Fu, Y. X., Requirement for membrane lymphotoxin in natural killer cell development. Proc. Natl. Acad. Sci. USA 1999. 96: 6336-6340.
28. Mackay, F., Majeau, G. R., Lawton, P., Hochman, P. S. and Browning, J. L., Lymphotoxin but not tumor necrosis factor functions to maintain splenic architecture and humoral responsiveness in adult mice. Eur. J. Immunol. 1997. 27: 2033-2042.
29. Mackay, F. and Browning, J. L., Turning off follicular dendritic cells. Nature 1998. 395: 26-27.
30. Wu, Q., Wang, Y., Wang, J., Hedgeman, E. O., Browning, J. L., and Fu, Y. X., The requirement of membrane lymphotoxin for the presence of dendritic cells in lymphoid tissues. J. Exp. Med. 1999. 190: 629-638.
31. Elewaut, D., Brossay, L., Santee, S. M., Naidenko, O. V., Burdin, N., De Winter, H., Matsuda, J., Ware, C. F., Cheroutre, H. and Kronenberg, M., Membrane lymphotoxin is required for the development of different subpopulations of NK T cells. J. Immunol. 2000. 165: 671-679.
32. Browning, J. L., Sizing, I. D., Lawton, P., Bourdon, P. R., Rennert, P. D., Majeau, G. R. X., Hession, C., Miatkowski, K., Griffiths, D. A., Ngam-ek, A., Meier, W. X. and Hochman, P. S., Characterization of lymphotoxin-αβ complexes on the surface of mouse lymphocytes. J. Immunol. 1997. 159: 3288-3298.
33. Pitti, R. M., Marsters, S. A., Lawrence, D. A., Roy, M., Kischkel, F. C., Dowd, P., Huang, A., Donahue, C. J., Sherwood, S. W., Baldwin, D. T., Godowski, P. J., Wood, W. I., Gurney, A. L., Hillan, K. J., Cohen, R. L., Goddard, A. D., Botstein, D. and Ashkenazi, A., Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer. Nature 1998. 396: 699-703.
34. Tamada, K., Shimozaki, K., Chapoval, A. I., Zhu, G., Sica, G., Flies, D., Boone, T., Hsu, H., Fu, Y. X., Nagata, S., Ni, J. and Chen, L., Modulation of T cell-mediated immunity in tumor and graft-versus-host disease models through the LIGHT costimulatory pathway. Nat. Med. 2000. 6: 283-289.
35. Wang, J., Foster, A., Chin, R., Yu, P., Sun, Y., Wang, Y., Pfeffer, K. and Fu, Y. X., The complementation of lymphotoxin deficiency with LIGHT, a newly discovered TNF family member, for the restoration of secondary lymphoid structure and function. Eur. J. Immunol. 2002. 32: 1969-1979.
36. Shao, H., Woon, M. D., Nakamura, S., Sohn, J. H., Morton, P. A., Bora, N. S. and Kaplan, H. J., Requirement of 137-mediated costimulation in the induction of experimental autoimmune anterior uveitis. Invest. Ophthalmol. Vis. Sci. 2001. 42: 2016-2021.
37. Caspi, R. R., Experimental autoimmune uveoretinitis in the rat and mouse. In: Coligan, J. E., Kruisbeek, A. M., Margulies, D. H., Shevach, E. M. and Strober, W. (Eds.) Current Protocols in Immunology. John Wiley & Sons, Inc., New York 1996, pp 15.6.1-15.6.18.